Jim Simons’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.51M Buy
1,575,772
+143,581
+10% +$859K 0.01% 1058
2025
Q4
$9.95M Buy
1,432,191
+247,519
+21% +$1.63M 0.02% 918
2025
Q3
$7.64M Buy
1,184,672
+423,689
+56% +$2.9M 0.01% 1229
2025
Q2
$5.07M Sell
760,983
-148,589
-16% -$764K 0.01% 1519
2025
Q1
$5.88M Buy
909,572
+414,400
+84% +$2.98M 0.01% 1331
2024
Q4
$3.99M Buy
495,172
+468,572
+1,762% +$3.86M 0.01% 1589
2024
Q3
$217K Buy
+26,600
New +$175K ﹤0.01% 3099
2024
Q2
Sell
-15,600
Closed -$165K 3505
2024
Q1
$165K Sell
15,600
-249,689
-94% -$2.18M ﹤0.01% 3271
2023
Q4
$2.13M Buy
+265,289
New +$1.93M ﹤0.01% 1913
2023
Q2
Sell
-1,135,289
Closed -$9.2M 3915
2023
Q1
$9.2M Buy
+1,135,289
New +$9.12M 0.01% 1125
2022
Q3
Sell
-544,043
Closed -$4.55M 4028
2022
Q2
$4.55M Sell
544,043
-609,746
-53% -$8.52M 0.01% 1638
2022
Q1
$26.4M Buy
1,153,789
+1,038,789
+903% +$25.4M 0.03% 609
2021
Q4
$3.17M Buy
115,000
+91,700
+394% +$2.45M ﹤0.01% 1820
2021
Q3
$650K Sell
23,300
-698,089
-97% -$19.8M ﹤0.01% 2773
2021
Q2
$21.1M Sell
721,389
-7,971
-1% -$241K 0.03% 729
2021
Q1
$23.1M Sell
729,360
-1,260,800
-63% -$37M 0.03% 684
2020
Q4
$41.4M Sell
1,990,160
-1,656,500
-45% -$30.9M 0.04% 418
2020
Q3
$56.7M Sell
3,646,660
-4,634,589
-56% -$79.8M 0.06% 349
2020
Q2
$151M Sell
8,281,249
-5,121,100
-38% -$90.2M 0.13% 149
2020
Q1
$208M Buy
13,402,349
+910,550
+7% +$22M 0.2% 104
2019
Q4
$374M Buy
12,491,799
+7,429,396
+147% +$193M 0.29% 61
2019
Q3
$111M Buy
5,062,403
+2,025,203
+67% +$46.3M 0.09% 249
2019
Q2
$76.6M Buy
3,037,200
+272,000
+10% +$6.46M 0.07% 340
2019
Q1
$68.3M Buy
2,765,200
+631,500
+30% +$15.1M 0.06% 379
2018
Q4
$39.4M Buy
2,133,700
+230,918
+12% +$5.49M 0.04% 533
2018
Q3
$48.8M Sell
1,902,782
-2,190,807
-54% -$50.2M 0.05% 447
2018
Q2
$95.1M Sell
4,093,589
-882,100
-18% -$18.2M 0.1% 219
2018
Q1
$79.2M Sell
4,975,689
-5,675,500
-53% -$106M 0.09% 268
2017
Q4
$221M Buy
10,651,189
+5,870,689
+123% +$93.1M 0.24% 61
2017
Q3
$68.5M Buy
4,780,500
+2,377,911
+99% +$36M 0.08% 301
2017
Q2
$41.6M Buy
+2,402,589
New +$28.8M 0.05% 460
2017
Q1
Sell
-2,913,089
Closed -$42.3M 3227
2016
Q4
$42.3M Buy
2,913,089
+2,480,600
+574% +$45.5M 0.07% 398
2016
Q3
$10.6M Buy
432,489
+320,600
+287% +$8.3M 0.02% 1114
2016
Q2
$2.25M Buy
+111,889
New +$3.17M ﹤0.01% 2129
2015
Q3
Sell
-107,789
Closed -$23.9M 3162
2015
Q2
$23.9M Sell
107,789
-368,048
-77% -$81.6M 0.05% 439
2015
Q1
$94.5M Buy
475,837
+436,848
+1,120% +$77.5M 0.2% 84
2014
Q4
$5.58M Buy
+38,989
New +$5.24M 0.01% 1207
2014
Q2
Sell
-47,189
Closed -$6.22M 2786
2014
Q1
$6.22M Sell
47,189
-317,000
-87% -$43.3M 0.01% 1137
2013
Q4
$42.8M Buy
+364,189
New +$39.9M 0.1% 217

Other funds holding BHC

Jim Simons's BHC Position: Q1 2026 in Review

Jim Simons increased its Bausch Health (BHC) stake by 10% in Q1 2026, buying an estimated $859K and bringing the position to 1,575,772 shares worth $8.51M. The position accounts for 0.01% of the portfolio, ranked #1058.

Jim Simons first reported a position in BHC in Q4 2013 and has held it in 39 quarters since. The position peaked at $374M in Q4 2019. 228 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Jim Simons held 1,575,772 shares of Bausch Health worth $8.51M as of Q1 2026.
  • Jim Simons bought 143,581 Bausch Health shares in Q1 2026, an estimated $859K.
  • Bausch Health made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1058 holding.
  • Jim Simons first reported a position in Bausch Health in Q4 2013 and has held it in 39 quarters since.
  • Jim Simons's Bausch Health position peaked at $374M in Q4 2019.
  • 228 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.